|
⚲
|
| Keyboard |
| Youngren Bryce
✚
|
|
|---|---|
| CIK # | 0001489625 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001489625] | |
| 4 | [0001489625] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cardlytics Inc | |
| Youngren Bryce |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cardlytics Inc CDLX
Common Stock
|
2020-08-17 | Sell | 5,000 | $81.28 | 406,400 |
|
Cardlytics Inc CDLX
Restricted Stock Units · derivative
|
2020-06-25 | Option exercise | 6,353 | $0.00 | |
|
Cardlytics Inc CDLX
Common Stock
|
2020-06-25 | Option exercise | 6,353 | ||
|
Cardlytics Inc CDLX
Restricted Stock Units · derivative
|
2020-06-02 | Grant | 2,023 | $0.00 | |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 21 | $83.77 | 1,759 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 10 | $86.26 | 863 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 72 | $85.77 | 6,175 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 24 | $84.55 | 2,029 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 15 | $83.77 | 1,257 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 29 | $86.26 | 2,502 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 205 | $85.77 | 17,583 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 69 | $84.55 | 5,834 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 41 | $83.77 | 3,435 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 1,510 | $86.26 | 130,253 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 10,536 | $85.77 | 903,673 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 3,516 | $84.55 | 297,278 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 2,123 | $83.77 | 177,844 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 15 | $86.26 | 1,294 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 106 | $85.77 | 9,092 |
|
Cardlytics Inc CDLX
Common Stock
|
2020-01-29 | Sell | 35 | $84.55 | 2,959 |
| showing 20 of 200 most recent transactions | |||||